SCHEMBL28872276

SCHEMBL28872276

NC(Cc1ccccc1)C(=O)OS(=O)(=O)O

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALPI P09923 1/20 0.58
PKM P14618 1/20 0.58
PTGS1 P23219 1/20 0.58
XIAP P98170 1/20 0.58
SLC7A5 Q01650 1/20 0.58
SLC15A1 P46059 3/20 0.50
SLC1A3 P43003 2/20 0.50
SLC1A2 P43004 2/20 0.50
SLC1A1 P43005 2/20 0.50
LTA4H P09960 1/20 0.47
CYP1A2 P05177 1/20 0.47
HDAC8 Q9BY41 2/20 0.45
SRR Q9GZT4 2/20 0.45
ANPEP P15144 1/20 0.44
RNPEP Q9H4A4 1/20 0.44
DNPEP Q9ULA0 1/20 0.44
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
CTSC P53634 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7155008 1.00 ALPI (0.58) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL8610379 0.85 ALPI (0.56) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL21553135 0.85 ALPI (0.56) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL6523945 0.85 SLC7A5 (0.57) SLC7A5HDAC8
SCHEMBL168029 0.85 SLC7A5 (0.57) SLC7A5HDAC8
SCHEMBL3476198 0.84 SLC7A5 (0.56) SLC7A5HDAC8
SCHEMBL27746572 0.84 ALPI (0.54) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL27831833 0.84 ALPI (0.54) ALPIPKMPTGS1XIAPSLC7A5
Phenylalanine Methyl Ester SCHEMBL14988957 0.83 MEN1 (0.57) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL2785098 0.82 SLC7A5 (0.70) ALPIPKMPTGS1XIAPSLC7A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119410678-A Method for optimizing antibody expression AMBRX公司 2025-02-11 CN claimed
CN-112313336-B Method for optimizing antibody expression AMBRX公司 2024-12-03 CN claimed
CN-117924503-A Humanized anti-Prostate Specific Membrane Antigen (PSMA) antibody drug conjugates AMBRX公司 2024-04-26 CN claimed
CN-116457023-A antibody-TLR agonist conjugates, methods and uses thereof AMBRX公司 2023-07-18 CN claimed
CN-115243726-A Interleukin-2 polypeptide conjugates and methods of use thereof 北京泰德制药股份有限公司 2022-10-25 CN claimed
CN-119410678-A Method for optimizing antibody expression AMBRX公司 2025-02-11 CN disclosed
CN-119410679-A Method for optimizing antibody expression AMBRX公司 2025-02-11 CN disclosed
CN-117924503-A Humanized anti-Prostate Specific Membrane Antigen (PSMA) antibody drug conjugates AMBRX公司 2024-04-26 CN disclosed
CN-117286182-A Methods and compositions for promoting production of proteins containing unnatural amino acids AMBRX公司 2023-12-26 CN disclosed
CN-110959041-B Methods and compositions for promoting production of proteins containing unnatural amino acids AMBRX公司 2023-09-29 CN disclosed
CN-116457023-A antibody-TLR agonist conjugates, methods and uses thereof AMBRX公司 2023-07-18 CN disclosed
CN-115243726-A Interleukin-2 polypeptide conjugates and methods of use thereof 北京泰德制药股份有限公司 2022-10-25 CN disclosed